Isavuconazonium and Atorvastatin Interaction

Understanding the Isavuconazonium and Atorvastatin Interaction

FDA-approved prescribing information for these two drugs flags their combination as a moderate-severity interaction. Isavuconazonium belongs to the Azole Antifungal class and Atorvastatin belongs to the HMG-CoA Reductase Inhibitor (Statin) class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Isavuconazonium can increase the amount of atorvastatin in your blood by slowing down how your body processes it. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Isavuconazonium has 9 total documented interactions on file in this dataset, and Atorvastatin has 36. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Use this combination with caution and tell your doctor if you notice any new side effects like muscle pain. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Isavuconazonium or Atorvastatin based on a web page, speak with your prescriber or pharmacist before making any change.